Clearwater Analytics ("Clearwater") and Enfusion, Inc. ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger ...

“Newer RNA interference therapeutics, patisiran and vutrisiran, show significant promise as an effective treatment for transthyretin amyloid cardiomyopathy (ATTR-CM),” Farhan Naeem ...

RNAi (RNA interference) is a biological process in which RNA molecules—microRNA (miRNA) and small interfering RNA (siRNA)—inhibit gene expression, typically by binding to messenger RNA (mRNA ...

The FDA has approved the first ever RNA interference drug – Alnylam’s Onpattro (patisiran) for the nerve damage caused by the rare disease hereditary transthyretin-mediated amyloidosis (hATTR ...

who have also signed separate partnerships to develop new therapies for neurological diseases using RNA interference (RNAi) technology. While there are RNAi products on the marketplace ...

Potential treatments need to be subject to the highest standards of safety and efficacy. Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson ...

McLaren's Oscar Piastri took a controlled, dominant victory in the Bahrain Grand Prix to close on team-mate Lando Norris in the world championship. The Australian was serene in the lead, calmly ...

Mindy Weisberger’s book, Rise of the Zombie Bugs, explores the sophisticated—and macabre—relationships between zombifying parasites and their hosts.